Histocell

Focus: Histocell is a Spanish biotechnology company specializing in cell therapy and regenerative medicine technologies, operating as a focused pre-revenue or early-stage biotech player.

Gene Therapy Cell Therapy

Profile data last refreshed 22h ago · AI intelligence enriched 2w ago

Open Jobs

About Histocell

AI assessmentNot Hiring

No open roles listed right now. Follow Histocell to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

6 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Reoxcare antioxidant dressing

Diabetes Mellitus

N/A

Clinical Trials (1)

NCT05413746REOXCARE Dressing to Improve Healing in Diabetic Foot Ulcers (DFU)

N/A

Help build intelligence for Histocell

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Opportunity to build early-stage expertise in high-growth therapeutic modalities (cell and gene therapy) with significant unmet medical need
Spain-based location offers European biotech access with potential regulatory pathways through EMA
Ground-floor role potential at a specialized regenerative medicine company with emerging technology platform

Watch Out For

No active clinical programs reported (0 Phase 1/2/3 trials) suggests very early discovery/development stage with extended path to value creation
Zero open job positions indicates minimal hiring activity, limited near-term career growth or organizational expansion

Generated by Claude from Histocell's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Antioxidant dressing

Hard-to-heal Wounds

N/A

Clinical Trials (1)

NCT03934671Evaluation of the Efficacy of an Antioxidant Dressing in Chronic Wound Healing

N/A

Adipose derived Stem Cell

Stroke

Phase 1

Clinical Trials (1)

NCT03570450Regenerative Stem Cell Therapy for Stroke in Europe 1-RESSTORE1

Phase 1